Hepatology

Top Story

Sovaldi with ribavirin safe, effective for children aged 3 years to 12 years

June 25, 2019
Perspective

AbbVie to acquire Allergan for $63 billion

June 25, 2019
Allergan will be acquired by AbbVie for approximately $63 billion in cash and stock, the two companies announced in a press release. Under a definitive transaction…
Breaking News

Trump issues executive order to make health care costs more affordable, transparent

June 24, 2019
President Donald J. Trump issued what he called a “groundbreaking” executive order Monday afternoon that seeks to make certain health care prices more…

Opdivo improves survival in unresectable HCC despite missing endpoint

June 24, 2019
Results from a phase 3 study of Opdivo for unresectable hepatocellular carcinoma revealed that the drug showed a trend toward improvement in overall survival but did not…

Chronic hepatitis B on the rise in Europe as acute cases decline

June 24, 2019
While most countries in the European Union and the European Economic Area have reported a decline in acute hepatitis B rates over the last decade, reports showed an…
More Headlines »
CME

Cirrhosis and Hepatic Encephalopathy – Managing Their Consequences and Complications

This activity is supported by an educational grant from Salix Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC.

Cirrhosis, or advanced fibrosis of the liver, can lead to serious health sequelae or death. However, substantial…
More »
GI Bookshelf

Question 20: A 58-Year-Old Female Underwent A Screening Colonoscopy That Showed A 2.5-Cm Flat Polyp In The Proximal Ascending Colon. I Tattooed The Area And Biopsied The Polyp, Which Was Initially Reported As Hyperplastic. What Should I Do?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Resource Centers
International Liver Congress

International Liver Congress

Video
Meeting News

VIDEO: Ascertaining patient’s social determinants takes some time

May 1, 2019
More »
Current Issues Current Issues
View the Current Issue
HCV Next